Pharmafile Logo
Pharmafocus logo
Advanced Search

drug development

Showing 15 posts of 46 posts found.

Science image

Drug development contracts: can lessons be learned from healthcare delivery?

March 16, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CCG, CRO, Les Rose, NHS, drug development, trials

There is a very good question to ask at the beginning of every project: “What does success look like?” If …

Feature

Alzheimer’s drug development ‘must speed up’

November 7, 2013
Research and Development, Sales and Marketing Alzheimer's, CEO, drug development

Alzheimer’s drugs cost three times the industry average to produce, according to a new draft report – and the way …

News

New venture a ‘game-changer’ for pharma

October 25, 2011
Research and Development Sir Christopher Evans, drug development

Sir Christopher Evans is looking to create a new venture that aims to improve on the drug development productivity of …

News

Innovation – is it science or art?

June 14, 2011
Manufacturing and Production, Research and Development creativity, drug development, innovation

In recent times new drug development has shown a substantial decline in the number of approved drugs for human use. …

Feature

The utility of next generation sequencing in drug development

November 3, 2010
Research and Development Dr Cheng Eng Ang, Illumina, Source BioScience, drug development, genomics, human genome, next generation sequencing

Drug development studies are extremely expensive, costing many millions of pounds and taking up to 12 years to bring a …

Feature

No sign of revival in R&D productivity

June 30, 2010
Research and Development drug development, industry, research

New data on the performance of the pharmaceutical industry shows efforts to raise productivity have not yet made an impact. …

News

Real World Development: Increasing value for patients

June 30, 2010
Research and Development Kinapse, drug development

The traditional drug development paradigm is protracted and costly, with many products failing to deliver commercial or clinical success.We propose …

Feature

Caution: you are entering phase III

December 8, 2008
Research and Development clinical trials, drug development, phase III

Patient: "I've just gone into phase III! What are my chances of coming through alive?" Doctor: "Well the prognosis is …

Feature

The Pharmafocus Interview: John Patterson

December 19, 2007
Research and Development, Sales and Marketing AstraZeneca, drug development, industry relations

John Patterson is an AstraZeneca man through-and-through, having spent nearly all his working life at the company. But over the …

Feature

Safety first

December 10, 2007
Research and Development, Sales and Marketing clinical trials, drug development, drug safety

There is a tide of change in drug safety within the pharmaceutical industry.  Internal and external forces are pushing drug …

Feature

Time is money in R&D

July 16, 2007
Research and Development clincial trials, drug development, productivity

There is a much-quoted statistic, which has become so hackneyed that it's largely ignored these days, but while you are …

Feature

HIV market: collaborative combinations

March 26, 2007
Research and Development, Sales and Marketing HIV, drug development, marketing

Two new HIV drugs, from Tibotec and Gilead, have been shown to be viable late-stage pipeline candidates. However, both TMC278 …

Feature

Gene therapy: the tailor-made treatment

June 28, 2006
Research and Development drug development, gene therapy

 At the risk of boring my audience, I really can't help beginning with yet another attack of nostalgia ,or rather …

Feature

EDC – turning the corner?

October 22, 2003
Research and Development EDC, drug development, electronic data capture, technology

Electronic Data Capture is a way of eliminating paper in the data collection process by capturing the data directly into …

Feature

Waiting for the upturn

October 15, 2003
Research and Development drug development, pipelines

Estimates vary considerably, but many analysts put the current cost of bringing a drug to market at around $800 million, …

Feature
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025